MarketFriction

Dr Lal Pathlabs Ltd

NSE LALPATHLAB · BSE 539524 · Healthcare Service Provider
₹2,005.10 +0.91%
NSE close2026-10-01
52 week range1,272.60 - 2,038.60
Market cap₹32,737 Cr.
P/E58.2
IPO 2015 · +629% since Results 04-11 Nifty 500Nifty Smallcap 50Nifty Smallcap 100Smallcap 250 Price band 20% Delivery 46.2%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales601539545602660597603670731660703798
Expenses424398401432458443434478506480516550
Operating Profit178141145170202154169192224179187248
OPM %30%26%27%28%31%26%28%29%31%27%27%31%
Other Income181818212225262825-62432
Interest877665555766
Depreciation363637353536363540424544
Profit before tax152116120150183138153181204124160229
Tax %27%29%28%28%29%29%-1%26%25%26%17%25%
Net Profit11182861081319815613415291132170
EPS in Rs6.554.875.066.377.735.789.267.908.995.407.8410.11
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales7919121,0571,2031,3301,5812,0872,0172,2272,4612,7632,891
Expenses5826757939109871,1451,5261,5271,6171,7641,9792,053
Operating Profit210238264294344436561490609698783838
OPM %26%26%25%24%26%28%27%24%27%28%28%29%
Other Income202731465551524269917075
Interest01111516303829222324
Depreciation282833387377108150144142162172
Profit before tax201237261301310394475344505625669717
Tax %34%34%34%33%27%25%26%30%28%21%24%
Net Profit133156172200228296350241362492510546
EPS in Rs7.999.3110.2411.9513.5517.4920.6914.3321.4229.1430.1332.34
Dividend Payout %15%16%22%25%44%57%29%42%0%41%68%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth13%12%11%14%
Compounded Profit Growth15%12%30%10%
Stock Price CAGR14%1%16%25%
Return on Equity22%21%22%22%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital5583838383838383838384168
Reserves2604255127058629491,1621,4181,5831,7662,0892,341
Borrowings2700000150533420247157199
Other Liabilities13411895128145341265309297357383433
Total Liabilities4756256909161,0911,3741,6612,3432,3832,4542,7133,140
Fixed Assets1501661522082094134471,3691,3051,2281,1681,256
CWIP14181031110155637
Investments38641061451851645965150114327423
Other Assets2863914145546947861,1448939231,1071,2151,454
Total Assets4756256909161,0911,3741,6612,3432,3832,4542,7133,140
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity122159171197219284398447456535569636
Cash from Investing Activity-113-163-137-172-100-26-212-449-287-24-303-422
Cash from Financing Activity-10-3213-55-190-139136-283-414-334-264
Net Cash Flow8-5237646748134-11497-68-50
Free Cash Flow87115120125177205339-28412479516463
CFO/OP112%108%102%110%110%110%115%103%115%110%105%104%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days171717141614151513131315
Inventory Days373133444070393828302730
Days Payable908997106111144132107127151127123
Cash Conversion Cycle-35-42-47-47-55-60-78-54-87-108-86-79
Working Capital Days-92719170-19-26-54-56-46-30-29
ROCE %48%47%43%38%35%32%33%29%18%25%29%28%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters54.61%54.60%54.60%54.60%53.92%53.91%53.91%53.79%53.21%53.21%53.21%53.19%
FIIs24.35%25.36%26.15%25.43%26.82%26.82%23.90%21.69%21.86%20.29%17.18%17.35%
DIIs8.85%9.27%9.40%12.42%12.60%12.88%15.79%17.62%18.22%19.20%21.37%21.59%
Government0.29%0.29%0.29%0.29%0.29%0.29%0.29%0.29%0.27%0.01%0.01%0.01%
Public11.48%10.12%9.24%6.95%6.02%5.82%5.84%6.22%6.07%6.94%7.88%7.48%
Others0.41%0.37%0.32%0.30%0.33%0.28%0.27%0.39%0.37%0.35%0.34%0.38%
No. of Shareholders1,60,6791,49,9011,46,7411,31,1891,16,6061,16,2361,15,6991,18,6561,12,7031,16,1671,14,5271,11,037

Fundamentals

Market Cap₹ 32,737 Cr.
Current Price₹ 1,950
Stock P/E58.2
Book Value₹ 150
ROCE28.0 %
ROE22.3 %
Dividend Yield0.72 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)14%
Compounded Profit Growth (TTM)10%
Consolidated figures.
Valuation
Market capRs 33,596 Cr
Enterprise valueRs 32,886 Cr
P/E (TTM)62.00x
Price to book13.39x
Price to sales11.62x
EV / EBITDA36.03x
EV / EBIT44.37x
EV / sales11.38x
Price to cash flow52.86x
Earnings yield1.61%
Dividend yield1.02%
P/E, 3-year average30.41x
P/B, 3-year average6.21x
P/E, 5-year average30.94x
P/B, 5-year average6.09x
Profitability
Operating margin (excl. other income)28.36%
Operating margin (incl. other income)30.90%
EBITDA margin31.57%
Pre-tax margin24.79%
Net profit margin18.75%
Net margin, latest quarter21.25%
ROE21.57%
ROCE27.47%
ROA17.25%
ROE, 3-year average22.05%
ROCE, 3-year average27.43%
ROA, 3-year average16.97%
ROE, 5-year average21.27%
ROCE, 5-year average26.05%
ROA, 5-year average15.65%
ROIC (approx.)31.41%
Tax rate23.81%
Other income / net worth2.80%
Growth
Sales growth (latest year)12.25%
Profit growth (latest year)3.62%
Sales CAGR, 3 years11.06%
Sales CAGR, 5 years11.81%
Profit CAGR, 3 years28.33%
Profit CAGR, 5 years11.60%
Sales growth QoQ13.52%
Profit growth QoQ29.09%
Sales growth YoY (latest quarter)19.10%
Profit growth YoY (latest quarter)28.02%
Per share
EPS (TTM)Rs 32.34
EPS (latest year)Rs 30.13
EPS (latest quarter)Rs 10.12
EPS, 3-year averageRs 43.75
EPS, 5-year averageRs 40.26
Book value per shareRs 149.69
Sales per shareRs 172.53
Cash flow per shareRs 37.93
Free cash flow per shareRs 27.63
Dividend per share (latest year)Rs 20.50
Dividend per share, 3-year averageRs 22.25
Dividend per share, 5-year averageRs 17.13
Dividends
Dividend payout68.05%
Dividend payout, 3-year average54.62%
Dividend payout, 5-year average45.03%
Efficiency
Asset turnover0.88x
Fixed asset turnover2.20x
Inventory turnover23.86x
Inventory days15 days
Debtor days15 days
Debtors turnover24.96x
Creditor days123 days
Cash conversion cycle-79 days
Working capital days-29 days
Leverage
Total debtRs 199 Cr
Cash and bankRs 910 Cr
Net debtRs -711 Cr
Debt to equity0.08x
Net debt / EBITDA-0.78x
Interest coverage30.37x
Current ratio (filing 2026-03-31)3.48x
Quick ratio (filing 2026-03-31)3.38x
Trade payables (filing 2026-03-31)Rs 181 Cr
Owners' fund to total sources79.88%
Debt to assets6.34%
Cash flow
Cash from Operating Activity (latest year)Rs 636 Cr
Cash from Investing Activity (latest year)Rs -422 Cr
Cash from Financing Activity (latest year)Rs -264 Cr
Net Cash Flow (latest year)Rs -50 Cr
Free cash flow (latest year)Rs 463 Cr
FCFE (approx.: FCF + change in debt)Rs 505 Cr
Cash from ops / profit, 5 years1.35x
Sales to cash flow4.35x
Statement figures
Net sales (TTM)Rs 2,891 Cr
Net sales (latest year)Rs 2,763 Cr
Sales (latest quarter)Rs 798 Cr
Operating profit excl. other income (latest year)Rs 783 Cr
Operating profit (latest quarter)Rs 248 Cr
Other income (TTM)Rs 75 Cr
EBITDA (TTM)Rs 913 Cr
PBDT (TTM)Rs 888 Cr
Profit before tax (TTM)Rs 717 Cr
Tax (latest year)Rs 159 Cr
Net profit (TTM)Rs 542 Cr
Net profit (latest year)Rs 505 Cr
Net profit (latest quarter)Rs 170 Cr
Depreciation (TTM)Rs 172 Cr
Depreciation (latest quarter)Rs 44 Cr
Interest (TTM)Rs 24 Cr
Cost of goods sold (latest year)Rs 1,047 Cr
Total expenditure (latest year)Rs 1,979 Cr
Total income (latest year)Rs 2,833 Cr
Share capitalRs 168 Cr
ReservesRs 2,341 Cr
Shareholders' fundsRs 2,508 Cr
Total assetsRs 3,140 Cr
Net blockRs 1,256 Cr
Capital work in progressRs 7 Cr
InvestmentsRs 423 Cr
ReceivablesRs 111 Cr
InventoryRs 44 Cr
Other liabilitiesRs 433 Cr
Shares outstanding (crore)16.76
Ownership
Promoter holding53.19% (-0.60 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 62.0 is at the 53th percentile of its own 9.4-year range (median 59.8, low 41.6, high 116.4).
P/B 13.39 is at the 64th percentile (median 12.61).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodLALPATHLABNifty 50Difference
1 week+2.2%-2.8% +5.0 pts
1 month+5.3%-6.8% +12.1 pts
3 months+21.8%-7.6% +29.5 pts
6 months+52.8%+0.4% +52.4 pts
1 year+23.0%-9.9% +32.9 pts
2 years+22.0%-13.6% +35.5 pts
3 years+58.9%+14.2% +44.7 pts
5 years+8.2%+27.9% -19.7 pts
143 mutual fund schemes hold about ₹6,327 Cr. Over three months 24 bought more and 92 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
HDFC Flexi Cap Fund0.71%808 -10%
UTI Flexi Cap Fund2.03%492 -10%
Aditya Birla SL Flexi Cap Fund1.53%445 +11%
SBI Large & Midcap Fund0.59%252 -7%
Nippon India Small Cap Fund0.30%250 -9%
Sundaram Mid Cap Fund1.53%227 -0%
Sundaram Mid Cap Fund1.53%222 -0%
Nippon India Multi Cap Fund0.39%222 -29%
HDFC ELSS-Tax Saver Fund1.38%221 -5%
Nippon India Pharma Fund2.04%194 -10%
HDFC Retirement Fund-Equity Plan1.94%135 -6%
UTI Mid Cap Fund1.01%130 -18%
SBI Dividend Yield Fund1.49%128 -4%
Mirae Asset Small Cap Fund2.19%125 -11%
NJ Flexi Cap Fund4.58%123 -6%
Tata Balanced Adv Fund1.38%121 -0%
Aditya Birla SL Small Cap Fund1.94%121 +7%
Mirae Asset Healthcare Fund2.77%98 -12%
ICICI Pru Small Cap Fund0.94%93 +9%
ICICI Pru Small Cap Fund0.94%90 +9%
SBI Healthcare Opp Fund1.47%85 +22%
Aditya Birla SL Midcap Fund1.12%78 -8%
Edelweiss Small Cap Fund1.07%78 -13%
Aditya Birla SL Midcap Fund1.12%75 -8%
Baroda BNP Paribas Multi Cap Fund2.01%70 -8%

Red flags

F-score 5 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Insider trades

NSE insider and takeover-code disclosures
DateWhoRoleSideSharesValueHow
2026-04-30Dr. Lal PathLabs Employees WelfareOtherother82,750Rs 9.44 CrESOP
2026-03-30Rahul SharmaDirectorsell1,000Rs 0.13 CrMarket Sale
2026-02-24Abhishek AggarwalEmployees/Designated Employeother1,500Rs 0.15 CrESOP
2026-02-24Dr. Lal PathLabs Employees WelfareOtherother2,024Rs 0.15 CrESOP
2026-02-17Dr. Lal PathLabs Employees WelfareOtherother1,876Rs 0.07 CrESOP
2026-02-09Jitender SharmaEmployees/Designated Employeother2,470Rs 0.36 CrPledge Creation
2026-01-30Rahul SharmaDirectorother4,000Rs 0.06 CrESOP
2025-12-31Rahul SharmaDirectorsell2,500Rs 0.37 CrMarket Sale
2025-12-30Sanjay KulshreshthaEmployees/Designated Employeother424Rs 0.00 CrESOP
2025-12-30Gaurav SharmaEmployees/Designated Employeother2,500Rs 0.25 CrESOP
2025-12-30Abhishek AggarwalEmployees/Designated Employesell1,750Rs 0.25 CrMarket Sale
2025-12-30Dr. Lal PathLabs Employees WelfareOtherother4,424Rs 0.25 CrESOP
Latest disclosed trades by insiders, promoters and large holders. Grants, option exercises and pledges show as "other". A filing is a fact, not a signal on its own.

Latest quarter

Jun 2026
Sales ₹798 Cr +19.1% vs Jun 2025. Net profit ₹170 Cr +26.9%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Vijaya Diagnostic Centre Ltd15,19281.020.5 %
Metropolis Healthcare Ltd11,66556.017.8 %
Thyrocare Technologies Ltd8,70848.235.4 %
Nephrocare Health Services Ltd6,67178.415.3 %
Suraksha Diagnostic Ltd1,84751.617.3 %
Krsnaa Diagnostics Ltd1,79118.112.7 %
3B Blackbio DX Ltd1,39625.125.5 %
One Global Service Provider Ltd1,04614.187.0 %
Health X Platform Ltd9230.03 %
Gaudium IVF and Women Health Ltd83035.929.3 %
Chandan Healthcare Ltd58122.123.3 %
Pramodini Medicare Ltd25914.941.8 %
Aspira Pathlab & Diagnostics Ltd1482.84 %
Choksi Laboratories Ltd13269.29.44 %
Star Imaging and Path Lab Ltd1316.8026.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-07-30Interim Dividend - Rs 5 Per Share
2026-06-25Dividend - Rs 4 Per Share
2026-02-05Interim Dividend - Rs 3.50 Per Share
2025-12-19Bonus 1:10.5000
2025-11-07Interim Dividend - Rs 7 Per Share
2025-08-06Interim Dividend - Rs 6 Per Share
2025-06-06Dividend - Rs 6 Per Share
2025-02-05Interim Dividend - Rs 6 Per Share
2024-11-05Interim Dividend - Rs 6 Per Share
2024-08-20Interim Dividend - Rs 6 Per Share
2024-06-10Dividend - Rs 6 Per Share
2024-02-13Interim Dividend - Rs 12 Per Share
2023-08-11Interim Dividend - Rs 6 Per Share
2023-08-11Dividend - Rs 6 Per Share
2022-08-05Interim Dividend - Rs 6 Per Share
2022-06-22Annual General Meeting/Dividend - Rs 6 Per Share
2021-08-18 Interim Dividend - Rs 6 Per Share
2021-07-20 Annual General Meeting/Dividend - Rs 8 Per Share
2021-02-09 Interim Dividend - Rs 6.00 Per Share
2020-11-18 Interim Dividend - Rs 6 Per Share
2020-03-05 Interim Dividend - Rs 6 Per Share
2019-11-20 Interim Dividend - Rs 6 Per Share
2019-08-02 Annual General Meeting/ Dividend - Rs 3.5 Per Share
2018-11-19 Interim Dividend - Rs 2.50 Per Share
2018-08-03 Annual General Meeting / Dividend- Rs 3 Per Share
2017-11-20 Interim Dividend Rs 1.50 Per Share
2017-07-12 Annual General Meetin/Dividend - Rs 1.70 Per Share
2017-02-13 Interim Dividend Rs 1.30 Per Share
2016-07-20 Annual Genral Meeting/Dividend Rs 2.45 Per Share
DateTypeWhat it says
2026-10-01General UpdatesGeneral Updates
2026-09-26General UpdatesGeneral Updates - Update on acquisition-SHL
2026-09-24General UpdatesAcquisition of 70% stake in SN Genelab Private Limited ( S N Gene ) from its existing Shareholders. Post acquisition, S N Gene shall become a Subsidia...
2026-09-24Board meeting outcomeOutcome of Board Meeting held on September 24, 2026.
2026-08-27General UpdatesGeneral Updates
2026-08-19General UpdatesIncorporation of a Step-Down Subsidiary Company
2026-08-06ESOPAllotment of 211050 Shares.
2026-07-30Concall / analyst meetTranscript
2026-07-26Director changeChange in Director(s) of the company.
2026-07-25Shareholder meetingVoting results.
2026-07-25Shareholder meetingProceedings of Annual General Meeting held on July 25, 2026
2026-07-24Concall / analyst meetLink of Recording
2026-07-24Investor PresentationInvestor Presentation
2026-07-24Press ReleaseA press release dated July 24, 2026, titled "Press Release on Un-audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30...
2026-07-24ESOPGrant of 119300 Stock Options.
2026-07-24General UpdatesAcquisition(s) :1. Took note that the Board of Dr Lal PathLabs FZCO, Dubai, Wholly Owned Subsidiary of the Company, approved acquisition of stake in S...
2026-07-24Record DateRecord date for the purpose of Dividend is 30-Jul-2026.
2026-07-24Board meeting outcomeOutcome of Board Meeting held on July 24, 2026.
2026-07-24DividendBoard of Directors at its meeting held on July 24, 2026, declared Interim Dividend of Rs. 5 per equity share.
2026-07-24Board meeting outcomeDr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-07-17General UpdatesGeneral Updates - Received an appellant order from Income Tax Department
2026-07-17Concall / analyst meetSchedule of meet
2026-07-01UpdatesLetter Dispatched To The Members Of The Company- Weblink Of The Annual Report FY 2025-26.
2026-07-01UpdatesSubmission of Business Responsibility and Sustainability Report for the Financial Year 2025-26
2026-07-01Shareholder meetingNotice of Annual General Meeting to be held on July 25, 2026
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Order dateForumCase
2021-07-23NCLTDr. Lal Pathlabs Ltd Vs M/s Aapka Urgicare Pvt Ltd.
Orders from NCLT, NCLAT and CESTAT naming the company. Click a row for the order.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Dr Lal Pathlabs Ltd?

Dr Lal Pathlabs Ltd (LALPATHLAB) has a market capitalisation of Rs 32,737 Cr. at the 2026-10-01 close.

What is the P/E ratio of Dr Lal Pathlabs Ltd?

Dr Lal Pathlabs Ltd trades at a P/E of 58.2 on trailing twelve-month profit, at the 2026-10-01 close.

What were Dr Lal Pathlabs Ltd's latest quarterly results?

In the Jun 2026 quarter, Dr Lal Pathlabs Ltd sales was Rs 798 Cr (+19.1% vs Jun 2025) and net profit was Rs 170 Cr.

What is the 52-week high and low of Dr Lal Pathlabs Ltd?

The 52-week high is Rs 2,038.60 and the 52-week low is Rs 1,272.60.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03